Endometriosis (EMT), referred to as endometriosis, has the following characteristics: 1. The incidence and recurrence rate of endometriosis are on the rise due to the change in lifestyle and fertility, early age of menarche, increased ovulation and menstruation, which has become a “modern disease” of modern women. 2.Hazardous, seriously affecting women’s health and quality of life: endoheterosis often causes pelvic pain, which can be manifested as dysmenorrhea, painful intercourse, long-term pelvic pain, abdominal wall endoheterosis pain, etc. 80% of endoheterosis patients suffer from pain; it also often makes women of childbearing age face infertility (about 50% of endoheterosis women with infertility); it can also be abnormal menstruation. Therefore, endometriosis is a serious threat to women’s health and quality of life. Most endometriosis is located in the pelvic organs and peritoneum, with ovarian endometriosis cysts (commonly known as “chocolate-like cysts”) being the most common, followed by the uterosacral ligament and other dirty peritoneum, vaginal diaphragm and other parts, which are often clinically referred to as ovarian, peritoneal and deep endometriosis. endometriosis. In addition, endometriosis can also invade other parts of the body, such as the bladder, ureter, lung, pleura, appendix, diaphragm, etc. It can also manifest as endoheterosis at the abdominal wall cesarean incision site and endoheterosis at the lateral perineal incision site. It grows in local infiltration. It is a disease that is difficult for gynecologists to deal with and confusing for patients and families, and is called “benign cancer” and “incurable disease”. 4.Endo is a hormone-dependent disease: Endo usually occurs in women of childbearing age and is related to the hormones secreted by the ovaries. After menopause, as the hormone level decreases, endo usually stops developing; however, when pregnant, the high progesterone status in the body of pregnant women will inhibit the growth of endo and even shrink endo lesions. The drugs for the treatment of endometriosis are mainly aimed at this hormonal dependence, either “pseudo-menopause therapy”, which mimics the situation of “menopause”, or “pseudo-pregnancy therapy”, which simulates the state of pregnancy. The aim of endometriosis treatment is “pseudo-menopause”. The aim of endometriosis treatment is to “reduce and remove the lesion, reduce and control the pain, treat and promote fertility, and prevent and reduce recurrence”. Treatment is often surgical, pharmacological and combined surgical and pharmacological, and some infertility patients require assisted reproduction. The choice of treatment method needs to be individualized according to the patient’s age, symptoms, lesion location and lesion extent as well as the patient’s different requirements for fertility. Surgery is mostly performed for pain, infertility and larger masses caused by endo, and laparoscopic surgery is the preferred surgical method. It is now considered that laparoscopic confirmation and combined surgical drug treatment is the gold standard of endo treatment. Many patients and their families may think that it is better to have the lesion of endo removed. However, unlike other benign gynecological diseases, endo is a “benign cancer” and is prone to recurrence. First of all, heavy endometriosis often has a wide range of lesions, the ectopic endometrium is highly invasive and heavily adhered, so it is often difficult to completely remove all the lesions during surgery, and even some tiny lesions are difficult to identify with the naked eye and can easily continue to proliferate. According to statistics, the recurrence rate is as high as 36%-70% at 5 years after surgery alone. Therefore, unlike what people think, everything is fine as long as the endometriosis lesion is removed surgically, and there is still a risk of recurrence after surgery. Therefore, endometriosis is a disease that requires long-term management, and the selection of an appropriate protocol to prevent recurrence of the disease after surgery is the key to treatment. Clinically, for young patients with urgent fertility requirements and mild endometriosis, postoperative menstrual cycle can be resumed and pregnancy is the best preventive measure for endometriosis, and the disease usually does not progress during pregnancy, and postpartum recurrence prevention measures are taken according to the situation. For patients with fertility requirements but with severe disease, GnRH-a treatment can be recommended for 3-6 months after surgery, followed by pregnancy as soon as possible. For those who have not conceived after six months of trying to conceive or who have severe endogamy, assisted reproduction techniques are recommended to help conceive. For older patients with endometriosis without fertility requirements, radical surgery is feasible; for younger patients without fertility requirements, after conservative surgery, they must be assisted with medication and long-term management to firmly prevent recurrence. Commonly used drugs are: gonadotropin-releasing hormone agonist (GnRH-a), progesterone, Manntirex ring, compounded oral short-acting contraceptive pills, Chinese medicine, etc. As for what medications and protocols to use, be sure to follow your doctor’s instructions and never take it lightly and let endo recur.